Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2018 Oct 12;8:15333. doi: 10.1038/s41598-018-32881-6

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer

Hai-Yuan Yang 1, Ding Ma 1, Yi-Rong Liu 1, Xin Hu 1, Jian Zhang 2, Zhong-Hua Wang 2, Gen-Hong Di 1,, Xi-Chun Hu 2, Zhi-Ming Shao 1
PMCID: PMC6182006  PMID: 30310090

Correction to: Scientific Reports 10.1038/s41598-017-00663-1, published online 25 April 2017

In Figure 2 the subgroup order is incorrect.

Figure 2.

Figure 2

Kaplan-Meier curves of overall survival (OS) in HER2-positive metastatic breast cancer (MBC) patients according to hormone receptor (HR) status and trastuzumab-containing palliative therapy (trast+/−).

HR+HER2+, trast+

HR−HER2+, trast−

HR+HER2+, trast+

HR−HER2+, trast−

should read:

HR+HER2+, trast+

HR−HER2+, trast+

HR+HER2+, trast−

HR-HER2+, trast−

The correct Figure appears below.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES